Asia Biotech Live
LATEST UPDATES » Vol 24, No 01, January 2020 – Empowering the Patient - Personalization of Diabetes Management       » First of its kind Human Heart-in-a-Jar Model for therapeutic solutions       » China's National Vaccine Tracking System set to be completed in 2020       » China's amended drug administration law kicks in       » Human activity puts Chinese plant biodiversity at risk, study finds       » Contributory effects of each brain cell type in development of Alzheimer's Disease      
App to revolutionise pain measurement and management
Mundipharma’s digital platform solution helps to transform how caregivers and doctors manage their patients’ pain, via artificial intelligence

Pain affects billions of people in the world. It has been difficult to measure or control this pain for the vast numbers of people affected by it. Many tests are too one-dimensional and only measure pain at one point of time, mostly determined by the physician.

Mundipharma has announced the development of painfocus, a revolutionary new end-to-end pain management solution that significantly increases the objectivity of pain measurement, something that has been historically difficult. This has the potential to transform how caregivers and doctors manage their patients’ pain.

It uses advanced machine learning that combines multiple physiology biomarkers captured using wearable devices to calculate the presence and severity of pain. They have integrated wearable biosensors with multiple form factors, such as wearable patch (worn on the chest), wrist watch, arm bands etc.

The app can capture, monitor and analyse data generated by patients in an inpatient or outpatient setting, and share with caregivers an accurate picture of health including level of pain, quality of life and general physiology in real-time via a web-based dashboard.

It also enables digital patient-caregiver communication, which is particularly significant for patients who do not have the ability to verbally explain how they are suffering.

painfocus has been tested in an early feasibility study conducted in multiple hospitals in South Africa from January to May 2018 that continuously monitored the physiology of knee arthroplasty patients using Everion physiology monitor. The study found significant correlations between patient-reported pain scores and the results calculated by painfocus in an ambulatory, real-world setting.

The digital healthcare solution was developed and tested in partnership with digital health technology company Biofourmis, which specializes in augmenting personalized care with digital therapeutics.

painfocus will further be evaluated in an investigator-initiated study in multiple public hospitals in Singapore, on how this solution can augment clinical care for patients in treatment. The study is being funded by Mundipharma.

They will be conducting a clinical trial with about 115 patients in Singapore General Hospital soon.

Click here for the complete issue.

news Joining Forces to Elevate Asia's Healthcare Industry
news 4th Global Feed Summit draws Feed Producers, Technology Providers, Raw Materials Suppliers to Bangkok for Key Discussions
news 2nd China Pharma Digital Innovation Summit to be held in Shanghai
news 2nd China Healthcare Digital Innovation Summit to be held in Shanghai

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy